Artwork for podcast Global Perspectives
What’s next for booming weight-loss drugs
20th March 2025 • Global Perspectives • Janus Henderson Investors
00:00:00 00:21:24

Share Episode

Shownotes

New GLP-1 weight-loss drugs have already hit $50 billion in annual sales – and look to have plenty of room to grow.

Portfolio Manager Dan Lyons joins this episode of Global Perspectives to provide an update on popular GLP-1 weight-loss therapies and discuss whether sales of the drugs can continue to grow and the impact on the overall healthcare sector.

Chapters

Video

More from YouTube